Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 2,5012,520 of 20,252 grants

Active NON-SBIR/STTR RPGS
Longitudinal assessment of benefits and harms of cannabis use among community-based cancer patients during initial cancer treatment
NATIONAL CANCER INSTITUTE Georgetown University United States 2023 – 2028

Despite federal prohibition on the sale or prescribing of cannabis and cannabinoids (CAC), their medical use has been legalized in 37 states. Although there is limited evidence of...

$7M
USD
Completed NON-SBIR/STTR RPGS
Germline Genetics and Risk of Prostate Cancer in Diverse Populations from the All of Us Program
NATIONAL CANCER INSTITUTE Fred Hutchinson Cancer Center United States 2023 – 2025

PROJECT SUMMARY Prostate cancer is the second most common cancer and the second leading cause of cancer death in US men, with African American men having the highest incidence and...

$1.75M
USD
Active NON-SBIR/STTR RPGS
The effectiveness, cost-effectiveness, and budget impact of interventions to improve the delivery of cervical cancer screening in Puerto Rico.
NATIONAL CANCER INSTITUTE Comprehensive Cancer Center/ Univ/Pr United States 2023 – 2028

PROJECT SUMMARY Cervical cancer incidence is increasing dramatically (2.5% per year) in Puerto Rico (PR), with increased occurrence of regional (1.7% per year) and distant (4.7% pe...

$5.43M
USD
Active NON-SBIR/STTR RPGS
Evaluating prostate cancer phenotype and genotype classification from circulating tumor DNA as biomarkers for predicting treatment outcomes
NATIONAL CANCER INSTITUTE Fred Hutchinson Cancer Center United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT Prostate cancer is the second most common cause of cancer mortality among men. The majority of these deaths are due to resistance to androgen deprivation t...

$5.67M
USD
Active NON-SBIR/STTR RPGS
Targeting metastatic tumors with engineered cellular therapies
NATIONAL CANCER INSTITUTE Brigham and Women'S Hospital United States 2023 – 2028

SUMMARY Metastatic brain tumors are the most commonly observed intracranial tumors. Patients with advanced breast cancer have a high propensity to metastasize to the brain with hum...

$3.85M
USD
Active NON-SBIR/STTR RPGS
Precision Risk Stratification and Screening for HCC among Patients with Indeterminate Liver Nodules
NATIONAL CANCER INSTITUTE Ut Southwestern Medical Center United States 2023 – 2028

PROJECT SUMMARY Large gaps in current strategies for risk stratification and surveillance contribute to frequent late-stage detection and poor outcomes in patients with hepatocellu...

$8.47M
USD
Active NON-SBIR/STTR RPGS
Molecular mechanisms driving therapy-induced lineage plasticity
NATIONAL CANCER INSTITUTE Weill Medical Coll of Cornell Univ United States 2023 – 2028

SUMMARY This proposal seeks Dr. Juan Francisco Linares’s salary as a Research Specialist to support Dr. Maria T. Diaz-Meco’s research program at the Weill Cornell Medicine Departme...

$1.61M
USD
Active NON-SBIR/STTR RPGS
Systematic Characterization and Targeting of Neomorphic Drivers in Cancer
NATIONAL CANCER INSTITUTE Oregon Health & Science University United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT More than 3 million somatic mutations and fusion genes have been identified in cancer. However, our ability to predict functional consequences and the ther...

$8.14M
USD
Completed NON-SBIR/STTR RPGS
HORMAD-specific TGF-beta resistant memory T cells for treatment of patients with Gastro-esophageal Cancer
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2023 – 2025

Project Summary This proposal addresses three major challenges in adoptive cellular therapy: 1) T cell persistence; 2) Tumor immune resistance and 3) Target epitope identification...

$13.11M
USD
Active NON-SBIR/STTR RPGS
Irreversible Electroporation (IRE) Combined with CD40 Agonism as In Situ Vaccine Therapy for Pancreatic Cancer
NATIONAL CANCER INSTITUTE University of California, San Diego United States 2023 – 2028

Up to 40% of patients with pancreatic cancer present with locally advanced pancreas cancer (LAPC), defined as localized (non-metastatic) but unresectable. Treatment of this patient...

$5.65M
USD
Active NON-SBIR/STTR RPGS
Personalizing Post-Polypectomy Surveillance for Colorectal Cancer Prevention
NATIONAL CANCER INSTITUTE Kaiser Foundation Research Institute United States 2023 – 2028

PROJECT SUMMARY AND ABSTRACT Screening is an established method for decreasing colorectal cancer (CRC) incidence and mortality. However, despite guidance supporting CRC screening i...

$6.59M
USD
Active NON-SBIR/STTR RPGS
Clinical breast cancer risk prediction models for women with a high-risk benign breast diagnosis
NATIONAL CANCER INSTITUTE University of Vermont & St Agric College United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT Over 1.7 million core needle breast biopsies are performed in the U.S. every year among women with either a palpable mass or a suspicious finding on breast...

$6.87M
USD
Active NON-SBIR/STTR RPGS
Development of New Technologies at Roswell Park to Further Cancer-Based Research and Treatment Through Genome Modification
NATIONAL CANCER INSTITUTE Roswell Park Cancer Institute Corp United States 2023 – 2028

Abstract The current application seeks salary support for Aimee Stablewski, PhD who serves as the Director of the Gene Targeting and Transgenic Shared Resource (GeTT) of Roswell Pa...

$3.25M
USD
Active NON-SBIR/STTR RPGS
Genetically engineered mouse model to improve therapy of NUT carcinoma
NATIONAL CANCER INSTITUTE Brigham and Women'S Hospital United States 2023 – 2028

NUT carcinoma (NC) is an aggressive squamous carcinoma driven by the BRD4-NUT fusion oncoprotein. NC affects all ages and is highly lethal (>90%), a median survival of 6.5 month...

$6.29M
USD
Active NON-SBIR/STTR RPGS
Metabolic targeting of heterogenous myelodysplastic syndrome stem cells
NATIONAL CANCER INSTITUTE University of Colorado Denver United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT The goal of this project is to define vulnerabilities that can be leveraged to comprehensively eradicate MDS stem cells (MDS-SCs). This objective is based...

$4.03M
USD
Completed SBIR-STTR RPGS
A democratized platform for mapping the spatial epigenome in tissue
NATIONAL CANCER INSTITUTE Atlasxomics Inc United States 2023 – 2025

PROJECT SUMMARY AtlasXomics Inc. is commercializing the next generation of spatial biology tools to help researchers understand the epigenetic mechanisms of disease. The goal of th...

$4.55M
USD
Active NON-SBIR/STTR RPGS
Label-Free Optical Redox Imaging for Pretreatment Prognosis of Early-Stage Triple Negative Breast Cancer
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2023 – 2028

Label-Free Optical Redox Imaging for Pretreatment Prognosis of Early-Stage Triple Negative Breast Cancer Abstract Triple negative breast cancer (TNBC) has significant intratumor va...

$6.27M
USD
Active NON-SBIR/STTR RPGS
Using the IL-1R1 and its ligands to optimize the T cell immune response to cancer
NATIONAL CANCER INSTITUTE Brigham and Women'S Hospital United States 2023 – 2028

IL-1α and β were discovered more than 50-years ago, and knowledge about these pleiotropic cytokines has grown exponentially since that time. Therapeutic use of these molecules has...

$5.87M
USD
Active NON-SBIR/STTR RPGS
Expanding early cancer detection with high throughput OCEANA - Ovarian Cancer Exosome Analysis with Nanoplasmonic Array
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2023 – 2028

Ovarian cancer (OvCa) remains the most lethal gynecologic cancer in the United States. Early detection through screening, particularly of high-risk populations, is an appealing str...

$8.94M
USD
Completed SBIR-STTR RPGS
Development of an immunomodulating peptide as a therapy for osteosarcoma in canine and human
NATIONAL CANCER INSTITUTE Pharmain Corporation United States 2023 – 2025

Osteosarcoma (OSA) is the most common primary malignancy of bone in children and adolescents, accounting for approximately 5% of all childhood tumors (www.cancer.gov). Osteosarcoma...

$9.95M
USD